Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


WEST PHARM SVC   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2021202020192018201720162015201420132012
Period End Date12/31/202112/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/2012
Sales2,831.602,146.901,839.901,717.401,599.101,509.101,399.801,421.401,368.401,266.40
Total Revenue2,831.602,146.901,839.901,717.401,599.101,509.101,399.801,421.401,368.401,266.40
Cost of goods and services sold1,655.801,379.101,234.201,172.001,086.201,007.70944.00973.60933.70878.70
Gross Profit1,175.80767.80605.70545.40512.90501.40455.80447.80434.70387.70
Research and development52.8046.9038.9040.3039.1036.8034.1037.3037.9033.20
Selling, general and administrative expenses362.80302.00272.70262.90246.00239.60233.00228.70234.90218.10
Restructuring charge (benefit)--------------------
Other expense (income), net(7.90)(12.00)2.50(1.90)(2.00)(29.80)(60.10)0.200.50(1.30)
Insurance settlement--------------------
Operating Income (Loss)752.30406.90296.60240.30225.80195.20128.60182.00162.40135.10
Interest expense8.208.208.508.407.808.1014.1016.5017.0016.70
Interest income1.001.403.802.101.301.101.603.501.901.80
Other nonoperating income3.801.20(0.10)6.703.101.60--------
Gain (Loss) on debt extinguishment----------------(0.20)(11.60)
Income (loss) before income taxes748.90401.30291.80240.70222.40189.80116.10169.00147.10108.60
Provision for income taxes107.2072.5059.0041.4080.9054.4026.3047.2040.2032.70
Current provision:Federal64.8028.9010.802.102.102.501.005.200.000.00
Current provision-State10.903.402.403.300.101.000.900.501.700.20
Deferred provision:Federal7.300.2010.301.4041.8021.80(13.20)7.709.203.30
Current provision:International74.4046.0030.5035.10(0.10)29.4033.3034.5038.2027.20
Deferred provision:International(50.20)(6.00)5.00(0.50)37.00(0.30)4.30(0.70)(7.50)2.00
Minority interests--------------------
Equity in Net Income of Affiliated Companies20.1017.408.907.609.208.205.805.305.404.80
Income from Continuing Operations--------------------
Discontinued operations, net of tax--------------------
Earnings (loss) from discontinued operations, net of tax--------------------
Income tax benefit from discontinued operations--------------------
Pretax income (loss) from discontinued operations--------------------
Pretax gain (loss) on disposal of business segment--------------------
Income (Loss) on disposal of discontinued operations, net of tax--------------------
Net Income (loss)--------------------
Less: Net income attributable to noncontrolling interests--------------------
Net income (loss) attributable to common shareholders661.80346.20241.70206.90150.70143.6095.60127.10112.3080.70
Net income (loss) for diluted net income per share--------------------
Basic:Continuing operations--------------------
Basic:Discontinued operations--------------------
Net income per share- Basic8.894.683.272.802.041.961.331.791.611.19
Dilution:Continuing operations--------------------
Dilution:Discontinued operations--------------------
Net income per share- Diluted8.674.573.212.741.991.911.301.751.571.15
Weighted Average Shares Outstanding (Basic)74.4073.9074.0073.9073.9073.3072.0070.9069.6068.10
Weighted Average Shares Outstanding (Diluted)76.3075.8075.4075.4075.8075.0073.8072.8071.4071.80